Clinical trial · Interventional
the Beijing Randomized Study Of Prostate Cancer Screening
The Randomized Controlled Trial of Prostate Cancer Screening in Beijing, China
NCT05961514CI-TRIAL-00071023BROPCSunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
BROPCS is a randomized trial study comparing the effectiveness of traditional systematic biopsies and bpMRI followed targeted biopsies with PSA \> 4ng/ml in initial screening.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| systemic biopsies | Diagnostic Test | — | UNRESOLVED |
| Target biopsies | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Traditional
- description
- The traditional/control arm consists of systematic biopsies of the prostate if PSA\>4ng/ml.
- interventionNames
- Diagnostic Test: systemic biopsies
- type
- EXPERIMENTAL
- label
- Experimental
- description
- The experimental arm consists of MRI tests and targeted biopsies if PI-RADS scores ≥3 or systematic biopsies if PSA\>10ng/ml.
- interventionNames
- Diagnostic Test: Target biopsies
Primary outcomes (1)
- measure
- detection of clinically significant prostate cancer （Gleason Score ≥7）
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 60 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. Healthy men aged 60-75 with a life expectancy of more than 10 years; 2. Residing continuously in the community for more than 3 years and not previously diagnosed with prostate cancer; 3. Willing to participate in this project. Exclusion Criteria: 1. Previously diagnosed with prostate cancer; 2. Previously diagnosed with any malignant tumor within the past 5 years; 3. Used medication within the past 3 months that can affect PSA values, mainly finasteride, dutasteride, and ketoconazole; 4. Recently had acute prostatitis, acute urinary retention, or underwent transurethral procedures (such as urethral dilation, urinary catheterization, cystoscopy, etc.) within the past week; 5. Have other serious illnesses or cannot perform activities of daily living independently.
References
Publications (0)
Data not yet available
No reference posted for this study.